Press Releases Year None20222021202020192018201720162015201420132012201120102009 Date Title Views Jun 27, 2022 Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology PDF Version View HTML Jun 02, 2022 Epizyme Presents Updates from SYMPHONY-1 Tazemetostat + R² Combination Study in Relapsed/Refractory Follicular Lymphoma at the 2022 ASCO Annual Meeting PDF Version View HTML May 17, 2022 Epizyme To Participate in H.C. Wainwright Global Investment Conference PDF Version View HTML May 10, 2022 Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update PDF Version View HTML May 03, 2022 Epizyme Announces Date of First Quarter 2022 Financial Results PDF Version View HTML Apr 06, 2022 Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version View HTML Mar 15, 2022 Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update PDF Version View HTML Mar 02, 2022 Epizyme to Participate in Upcoming Healthcare Conferences in March PDF Version View HTML Mar 01, 2022 Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update PDF Version View HTML Feb 22, 2022 Epizyme Announces Date of Fourth Quarter and Full Year 2021 Financial Results PDF Version View HTML Pagination Current page 1 Page 2 Next page next › Last page last »
